How Big Is the Bladder Cancer Market | Trends 2031

Q: How large is the bladder cancer market?

The bladder cancer market was estimated at USD 6.0 billion in 2024 and is projected to reach USD 11 billion by 2031.

Q: What is driving the bladder cancer market growth?

Rise in disease incidence, novel drug approvals, and immunotherapy uptake are driving the growth of market.

Q: What are the current trends in bladder cancer treatment?

Non-invasive diagnostics, immunotherapy, and targeted precision treatments are the recent trends of the market.

Q: What challenges affect this market?

High treatment costs, limited access to new therapies in low-income regions, and drug resistance are the challenges of market.

Q: Which regions are leading in market adoption?

North America dominates due to robust R&D and access to advanced therapies and Asia-Pacific is growing rapidly.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA5088

Publication Date: Jul 2025

What is the size of the Bladder Cancer Market?

According to 6Wresearch internal database and industry insights, the Global Bladder Cancer Market was exhibited at USD 6.0 billion in 2024 and is projected to reach USD 11 billion by 2031, growing at a CAGR of 9.1% during the forecast period 2025–2031.

Due to rising incidence of bladder cancer globally, increasing adoption of immunotherapy, and advancements in diagnostic imaging technologies, the market is expected for the robust growth in the coming years.

Key Growth Factors of the Bladder Cancer Market

Increasing global prevalence of bladder cancer, especially in the aging population
Growing approval and adoption of immune checkpoint inhibitors
Advancements in minimally invasive diagnostics and molecular testing
Government initiatives for early detection and cancer screening
Rising healthcare expenditure and awareness in emerging markets

Bladder Cancer Market Trends

Bladder cancer market is moving forward with the recent trends which include a shift toward non-invasive diagnostic tools such as urine-based biomarkers and liquid biopsy. Particularly in the Immunotherapies where PD-1/PD-L1 inhibitors, are becoming a first-line treatment for advanced bladder cancer. Further, the combination therapies and precision medicine approaches are being increasingly explored in clinical trials.

Emerging Developments in the Bladder Cancer Market

Bladder cancer market has numbers of emerging developments which include research in gene therapy, antibody-drug conjugates (ADCs), and CAR-T cell therapies specifically for urothelial carcinoma. Artificial intelligence is being used to enhance bladder cancer diagnosis through imaging. Further, partnerships between biotech companies and cancer research centres are accelerating the development of novel treatment modalities.